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Scintillation proximity radioimmunoassay (SPA) systems, first dcscribed in 1979 by Hart and Greenwald,' are based on the activation of a Auorophor integrated in antibody-coated beads. Since the path length of \j emission from tritium decay. or from '"I Auger electron emission, is very short, only the antibody-bound radiolabelled ligand which is in close proximity to the bead activates the fluorophor. The light produced by activated microspheres is counted in a scintillation counter. The free ligand itself does not induce photon emission. Thus, it is possible to measure antibody-bound radioactivity without the need for the physical separation of bound and free hormone. Therefore an improvement in intra-assay variation may be expected as well as greater suitability for automation. We set out to develop SPAS for plasma cortisol and aldosterone using commercially available fluomicrospheres.2
METHODS

Conventional radioimrnunoassays
Direct radioimmunoassays (RIAs) for the determination of plasma cortisol3 and aldosterone4
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were performed as described previously. In short, for the RIA of cortisol, plasma samples and standards were diluted 1:100 and heated for 60min at 70°C to eliminate interference from plasma-binding proteins. The final dilution of the cortisol antiserum in the RIA was I :48 000. Antiserum-bound and free cortisol were separated by adsorption of free cortisol to dextran-coated charcoal. In the aldosterone RIA interference from corticosteroid-binding globulin (CBG) was inhibited by the addition of 8-anilino-lnaphthalene-sulphonic acid (ANS, Merck, Darmstadt, Germany) to the incubation mixture. The final dilution of the antiserum in the RIA was 1 :96 000. Antiserum-bound and free aldosterone was separated by the addition of dextrancoated charcoal.
Scintillation proximity assays
SPA was performed in duplicate in miniscintillation vials (Milk6 vials, Lumac BV, Netherlands). For the assay of cortisol, 50 p L of sample or standard (O-I%'pmol/L in steroid-free plasma) was diluted 1:100 in ethanol in water (5% v/v) and heated as described above. O . I % w/v of lysoryme were added. After 2 h incubation at room temperature 150pL of fluomicrospheres coated with anti-rabbit IgG antibodies (Amersham RPN 140, Amersham, UK) were added. The vials were incubated ovcrnight on an orbital shaker at 4°C and were counted for radioactivity for 4min in a refrigerated Packard TriCarb 460C counter (energy range 0-999 KeV). For the SPA of aldosterone a standard curve was prepared with 100 pL of steroid-free plasma and 100pL of 0.2% v/v ethylene glycol in water (EGW) containing 0-10 nmol/L of aldosterone. To 100pL of the samples 100pL of EGW was added. To the samples and standards 50pL of 'H-aldosterone (20 000 dpm) and 50pL of sheep antiserum to aldosterone (final dilution I :72 000) in 0.1 M borate buffer pH 8.6 containing 0.1 Yo v/v human 7-globulin (Beriglobulin. Behring Werke, Marburg, Germany) and 1.0% w/v of ANS were added. After 2 h incubation at room temperature I50pL of fluomicrospheres coated with anti-sheep IgG antibodies (Amersham RPN 142) were added. The vials were incubated and counted as described above.
RESULTS AND DISCUSSION
The levels of plasma cortisol measured by RIA and SPA were in excellent agreement (rpear,c,n = 0.996, P < 0,00I)( Fig. I) . The intraassay coefficient of variation was 5.0% in the RIA and 6.3% in the SPA in 20 samples with a mean concentration of 0.37 pmol/L (range 0.20-0.55piol/L). The standard curves of the SPA and RIA for cortisol were comparable with respect to precision, sensitivity, non-specific binding and apparent K, of the antibody ( Table  I) . The precision profiles' were almost supcriniposable ( Fig. 2a) .
To determine the appropriate dilution of the cortisol antiserum in the SPA, an antiserum dilution curve was prepared using the SPA reagent and working dilutions of the antiserum ranging from I :200 to 1 : 100 000. The SPA signal is depicted in Fig. 3 . To determine the percentage binding, the vials containing the SPA incubation IgG binding capacity of the SPA-reagent was exceeded.
The standard curve of the SPA for aldosterone was comparable to the RIA standard curve, demonstrating that the SPA reagent can be used for the determination of aldosterone (Table 1 , Fig. 2b ). For the same reasons as outlined above for the cortisol SPA, in the aldosterone SPA the antiserum dilution was less and the tracer concentration twice higher than in the RIA. Plasma aldosterone levels measured by SPA in a limited number of samples were higher (1.5 to 2.5 times) than the levels measured by direct RIA. Moreover the non-specific binding in the SPA was considerably lower than in the RIA (Table  I) . It should be noted, however, that non-specific binding in the SPA refers to radioactivity which is not bound to the beads and yet produces a signal, though very weak. Conversely, in the RIA, non-specific binding refers to any radioactivity which is not taken up by the dextrancoated charcoal in the absence of first antibody. Thus tracer bound to plasma transport proteins directly adds to the bound fraction in the RIA whereas in the SPA binding to plasma proteins is not detected but occurs at the expense of the bound fraction. The discrepancy between the non-specific binding in the SPA and the RIA suggests that ANS does not completely inhibit the binding of aldosterone t o plasma carrier proteins. Since the standard curve for the aldosterone assays was prepared in charcoal-stripped plasma the protein content of this plasma is lower than the mean protein content of samples. Therefore residual binding to CBG is likely to be higher in the samples. As a consequence the specific binding to the beads will be relatively lower in the samples than in the standard curve leading to an overestimation of the level of aldosterone in plasma.
In this study we have demonstrated that the SPA technology can be applied to the determina- reagent ( S P A cpm 0 ) . The i,icil.c conruining the incuhaiion mixture were centrifuged und un uliyuul of 1he .wpernatunl M'US counted ufier the oddition of liquid .scintillution cocktail. From t h i~ unbound rudiouctivity in (he supernatant the hound rudiouctivity was culculuted and a BIT curve was con.vtruc,ted ( + ). mixture were centrifuged. Subsequently an aliquot of the supernatant as well as the total radioactivity added to the vials were counted in a p-scintillation counter after the addition of liquid scintillation cocktail. From the free radioactivity in the supernatant and the total radioactivity the percentage binding was calculated (Fig. 3 ) .
The counting efficiency of the fluomicrospheres for tritium was 32% of the efficiency obtained with a conventional liquid scintillation cocktail, rather than the 62% mentioned in the product information supplied by the manufacturer. To maintain counting precision without prolonging counting times, the total concentration of radiolabelled cortisol used in the SPA was twice that in the RIA. In order to obtain a similar initial per cent binding, the final dilution of the antibody in the SPA had to be less than in the RIA (1:35000 vs 1:48000). At working dilutions of the antiserum less than 1 : 1600 the TABLE I . The lower limit of detection ( D L ) defined as the least amount of hormone distinguishahle at 3 SD ,from the initial non-specific binding ( N S B ) , initial binding ( B , ) , ED,,, and Lipparent K,, of 
